Requirement On Site-specific Production Of Basic Drugs Removed in China’s Medical Reforms
This article was originally published in PharmAsia News
Executive Summary
The drafting of a basic drug system is an integral part of medical system reforms. After numerous reviews, a controversial article on "site-specific production and unified distribution of basic drugs" will be removed from the draft. Without this requirement, generic drug companies will have a more competitive edge. The pricing of basic drugs is another highlight of the draft. The government will set the retail price index for basic drugs. In addition, the compilation of a 2009 basic drug catalogue is continuing. The number of selected basic drugs has been cut to about 400 medicines from an original 756. (Click here for more